Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Clinical trial NCT03748134 · COMPLETED
Trial details
- NCT number
- NCT03748134
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-24
- Primary completion
- 2021-09-09
- Enrollment
- 746
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.